Hello, Fool! | Login | Signup | My Fool
Aug 21, 2008 8:59 PM ET | Site Changes | Help
The Company develops, manufactures and markets pharmaceuticals, surgical equipment and devices and consumer eye care products to treat diseases and disorders of the eye.
View Ticker Page (ACL)
Results 1 - 10 of 38 : 1234
Recs
overley (86.11) Submitted: 10/10/06 7:25 PM : Start Price: $105.97 ACL Score: 66.35
As an eye doc, this is my favorite eye care company. It has been a leader in opthalmic drug, eg, vigamox, patanol, nevanac, contact lens solution, and surgical devices. This is a best of breed.
Report this Post Replies: 3 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
smitty012 (74.45) Submitted: 4/12/07 5:27 PM : Start Price: $132.74 ACL Score: 40.41
Aging boomer population and more $$ being spent on healthcare in US than anywhere.From Zacks.com: Alcon, Inc. exceeded analysts’ earnings expectations in 13 out of the past 16 quarters. After issuing bullish guidance for 2007, analysts r...
Report this Post Replies: 0 | Reply | Permalink
hazelnut283 (92.36) Submitted: 12/25/06 5:34 PM : Start Price: $109.77 ACL Score: 64.79
While this is a mid- to large-cap stock and has gone through a rough patch this year, I still think Alcon has the potential to outperform its competitors. It does extensive research to improve it's eye-care services and has much potential to grow and...
Report this Post Replies: 2 | Reply | Permalink
willjohn66 (87.23) Submitted: 12/28/06 8:56 AM : Start Price: $108.79 ACL Score: 67.21
Large number of products are geared toward an aging population.
KatWoman50 (95.94) Submitted: 4/19/07 11:08 AM : Start Price: $135.04 ACL Score: 39.40
Based on the chart, 29 P/E, and positive CAPS ratings.
Elektrawoman (97.60) Submitted: 5/04/07 9:56 AM : Start Price: $132.15 ACL Score: 44.42
Eye problems are erased with correcting vision. As the average life span grows so does eye problems. Surgical technology - always needed.
gustavojp (98.62) Submitted: 7/24/07 6:25 PM : Start Price: $141.95 ACL Score: 36.21
results better than expected and a growing demand in healthcare will provide a good performance in the nexts years
rufianno (97.41) Submitted: 8/29/07 12:25 PM : Start Price: $130.51 ACL Score: 42.79
BUY AND HOLD
gryfonclaw (65.04) Submitted: 8/03/07 3:18 PM : Start Price: $134.84 ACL Score: 38.28
Old people need to see.
chk999 (99.99) Submitted: 9/11/07 11:33 AM : Start Price: $135.84 ACL Score: 38.56
This is a Value Line pick, where the timeliness, safety, technicals and valuation all looked good.
Terms & Conditions
RSS Headlines
Fool UK